Literature DB >> 8501072

The Chlamydia trachomatis Mip-like protein is a lipoprotein.

A G Lundemose1, D A Rouch, C W Penn, J H Pearce.   

Abstract

The Mip-like protein of Chlamydia trachomatis is similar to the Mip protein of Legionella pneumophila and may be equally important for the initiation of intracellular infection. This article presents data which identify the chlamydial Mip-like protein as a lipoprotein. The amino acid sequence of the Mip-like protein contains a signal peptidase II recognition sequence, as is seen in procaryotic lipoproteins. Palmitic acid was incorporated into the recombinant chlamydial Mip-like protein. Globomycin, known to inhibit signal peptidase II, inhibited processing of the recombinant Mip-like protein. Labelling of chlamydial organisms with palmitic acid revealed incorporation into the native Mip-like protein.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8501072      PMCID: PMC204771          DOI: 10.1128/jb.175.11.3669-3671.1993

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  22 in total

1.  The structure of signal peptides from bacterial lipoproteins.

Authors:  G von Heijne
Journal:  Protein Eng       Date:  1989-05

2.  Chlamydia trachomatis Mip-like protein has peptidyl-prolyl cis/trans isomerase activity that is inhibited by FK506 and rapamycin and is implicated in initiation of chlamydial infection.

Authors:  A G Lundemose; J E Kay; J H Pearce
Journal:  Mol Microbiol       Date:  1993-03       Impact factor: 3.501

3.  Hypothesis about the function of membrane-buried proline residues in transport proteins.

Authors:  C J Brandl; C M Deber
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

4.  A Legionella pneumophila gene encoding a species-specific surface protein potentiates initiation of intracellular infection.

Authors:  N P Cianciotto; B I Eisenstein; C H Mody; G B Toews; N C Engleberg
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

5.  Extracellular pullulanase of Klebsiella pneumoniae is a lipoprotein.

Authors:  A P Pugsley; C Chapon; M Schwartz
Journal:  J Bacteriol       Date:  1986-06       Impact factor: 3.490

6.  A single amino acid determinant of the membrane localization of lipoproteins in E. coli.

Authors:  K Yamaguchi; F Yu; M Inouye
Journal:  Cell       Date:  1988-05-06       Impact factor: 41.582

7.  Ultrastructural studies on the intracellular fate of Chlamydia psittaci (strain guinea pig inclusion conjunctivitis) and Chlamydia trachomatis (strain lymphogranuloma venereum 434): modulation of intracellular events and relationship with endocytic mechanism.

Authors:  C J Prain; J H Pearce
Journal:  J Gen Microbiol       Date:  1989-07

8.  Lipoprotein-28, a cytoplasmic membrane lipoprotein from Escherichia coli. Cloning, DNA sequence, and expression of its gene.

Authors:  F Yu; S Inouye; M Inouye
Journal:  J Biol Chem       Date:  1986-02-15       Impact factor: 5.157

9.  Export and secretion of the lipoprotein pullulanase by Klebsiella pneumoniae.

Authors:  C d'Enfert; C Chapon; A P Pugsley
Journal:  Mol Microbiol       Date:  1987-07       Impact factor: 3.501

10.  Inhibition of prolipoprotein signal peptidase by globomycin.

Authors:  I K Dev; R J Harvey; P H Ray
Journal:  J Biol Chem       Date:  1985-05-25       Impact factor: 5.157

View more
  10 in total

1.  Chlamydial serology: comparative diagnostic value of immunoblotting, microimmunofluorescence test, and immunoassays using different recombinant proteins as antigens.

Authors:  S Bas; P Muzzin; B Ninet; J E Bornand; C Scieux; T L Vischer
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

2.  Identification of immunologically relevant proteins of Chlamydophila abortus using sera from experimentally infected pregnant ewes.

Authors:  P X Marques; Puneet Souda; J O'Donovan; J Gutierrez; E J Gutierrez; S Worrall; M McElroy; A Proctor; C Brady; D Sammin; H F Basset; Julian P Whitelegge; B E Markey; J E Nally
Journal:  Clin Vaccine Immunol       Date:  2010-06-16

Review 3.  Microbial peptidyl-prolyl cis/trans isomerases (PPIases): virulence factors and potential alternative drug targets.

Authors:  Can M Ünal; Michael Steinert
Journal:  Microbiol Mol Biol Rev       Date:  2014-09       Impact factor: 11.056

4.  Infection of Acanthamoeba castellanii by Chlamydia pneumoniae.

Authors:  A Essig; M Heinemann; U Simnacher; R Marre
Journal:  Appl Environ Microbiol       Date:  1997-04       Impact factor: 4.792

5.  Molecular characterization of a lipid-modified virulence-associated protein of Rhodococcus equi and its potential in protective immunity.

Authors:  C Tan; J F Prescott; M C Patterson; V M Nicholson
Journal:  Can J Vet Res       Date:  1995-01       Impact factor: 1.310

6.  Molecular characterization and subcellular localization of macrophage infectivity potentiator, a Chlamydia trachomatis lipoprotein.

Authors:  Laurence Neff; Sawsan Daher; Patrick Muzzin; Ursula Spenato; Fazil Gülaçar; Cem Gabay; Sylvette Bas
Journal:  J Bacteriol       Date:  2007-04-20       Impact factor: 3.490

7.  Characterization of a Legionella micdadei mip mutant.

Authors:  W A O'Connell; J M Bangsborg; N P Cianciotto
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

8.  Lipoprotein biosynthesis as a target for anti-Wolbachia treatment of filarial nematodes.

Authors:  Kelly L Johnston; Bo Wu; Ana Guimarães; Louise Ford; Barton E Slatko; Mark J Taylor
Journal:  Parasit Vectors       Date:  2010-10-14       Impact factor: 3.876

9.  Comprehensive in silico prediction and analysis of chlamydial outer membrane proteins reflects evolution and life style of the Chlamydiae.

Authors:  Eva Heinz; Patrick Tischler; Thomas Rattei; Garry Myers; Michael Wagner; Matthias Horn
Journal:  BMC Genomics       Date:  2009-12-29       Impact factor: 3.969

10.  Streptomyces chrysomallus FKBP-33 is a novel immunophilin consisting of two FK506 binding domains; its gene is transcriptionally coupled to the FKBP-12 gene.

Authors:  A Pahl; U Keller
Journal:  EMBO J       Date:  1994-08-01       Impact factor: 11.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.